<?xml-stylesheet type='text/xsl' href='rsspretty.xsl' version='1.0'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.law360.com/company_articles/2225" rel="self" type="application/rss+xml"/>
    <title>Law360: Kenyon &amp; Kenyon </title>
    <link>http://www.law360.com/</link>
    <description>Latest articles for organization: Kenyon &amp; Kenyon </description>
    <copyright>Copyright 2009 Portfolio Media, Inc.</copyright>
    <language>en-US</language>
    <image>
      <url>http://www.law360.com/images/headings/logo.gif</url>
      <title>Law360</title>
      <link>http://www.law360.com/</link>
    </image>
    <item>
      <title>Fed. Circ. Says Ads Invalidated Supplement Patent</title>
      <link>http://www.law360.com/articles/135318</link>
      <description>A federal appeals court on Thursday struck down infringement claims for a bodybuilding supplement patent held by Iovate Health Sciences Inc. and the University of Florida Research Foundation, ruling that certain fitness magazine ads describing the product had rendered the patent obvious. </description>
      <guid>http://www.law360.com/articles/135318</guid>
    </item>
    <item>
      <title>Teva Drops 2 Copaxone Claims Against Sandoz</title>
      <link>http://www.law360.com/articles/134825</link>
      <description>Teva Pharmaceuticals Industries Ltd. has dropped claims for unfair competition and trade secrets misappropriation against Sandoz Inc. and parent company Novartis AG in a patent dispute over the multiple sclerosis drug Copaxone.</description>
      <guid>http://www.law360.com/articles/134825</guid>
    </item>
    <item>
      <title>Last Claim Survives In Tire Pressure Patent Suit</title>
      <link>http://www.law360.com/articles/133631</link>
      <description>Patent-holding company MHL Tek LLC&#8217;s suit will continue against major automakers including BMW AG and Nissan Motor Co. Ltd. after a judge refused to throw out its sole remaining claim of infringement of a patent for tire pressure monitoring systems.</description>
      <guid>http://www.law360.com/articles/133631</guid>
    </item>
    <item>
      <title>Infosint Seeks $43M Damages In Citalopram Suit</title>
      <link>http://www.law360.com/articles/132727</link>
      <description>Infosint SA has asked a judge to increase a $15 million reasonable royalty award that a jury issued for Lundbeck A/S and Forest Laboratories Inc.'s alleged infringement of a patent for making the antidepressant citalopram, arguing that it should receive additional damages and interest totaling almost $43 million.</description>
      <guid>http://www.law360.com/articles/132727</guid>
    </item>
    <item>
      <title>Roche Drops NJ Boniva Suits After Teva Pulls ANDA </title>
      <link>http://www.law360.com/articles/132090</link>
      <description>Twin patent lawsuits brought by Hoffmann-La Roche Inc. accusing generic-drug maker Teva Pharmaceuticals USA Inc. and its Gate Pharmaceuticals division of infringing patents related to a popular osteoporosis drug have been dismissed because Teva dropped an application to make generic Boniva. </description>
      <guid>http://www.law360.com/articles/132090</guid>
    </item>
    <item>
      <title>IP Lawyers Form New Washington Boutique</title>
      <link>http://www.law360.com/articles/131797</link>
      <description>Three lawyers who previously worked at Morgan Lewis &amp; Bockius LLP, Foley &amp; Lardner LLP and Arrowhead Research Corp. have launched a new Washington-based intellectual property boutique &#8212; Fanelli Strain &amp; Haag PLLC.</description>
      <guid>http://www.law360.com/articles/131797</guid>
    </item>
    <item>
      <title>The Patentability Of 'Personalized Medicine' Claims</title>
      <link>http://www.law360.com/articles/126495</link>
      <description>In its first precedential opinion applying the &#8220;machine or transformation&#8221; test of In re Bilski to claims directed to methods of treating patients, the Federal Circuit held that steps implicitly requiring the assay of specimens are sufficiently transformative even if they do not require use of any particular instrument or assay method, say Charles A. Weiss and Ashton J. Delauney of Kenyon &amp; Kenyon LLP.</description>
      <guid>http://www.law360.com/articles/126495</guid>
    </item>
    <item>
      <title>Jury Awards Infosint  $15M In Lexapro Patent Fight</title>
      <link>http://www.law360.com/articles/128894</link>
      <description>Lundbeck A/S and Forest Laboratories Inc. will have to pay Infosint SA a $15 million reasonable royalty award now that a federal jury has ruled that Infosint's patent for making the antidepressant citalopram is valid.
</description>
      <guid>http://www.law360.com/articles/128894</guid>
    </item>
    <item>
      <title>Teva Hits Back In Gilead Patent Suit Over HIV Drug</title>
      <link>http://www.law360.com/articles/127717</link>
      <description>Teva Pharmaceutical Industries Ltd. has struck back with patent invalidity counterclaims against rival Gilead Sciences Inc. in an infringement case involving drug treatments for HIV.</description>
      <guid>http://www.law360.com/articles/127717</guid>
    </item>
    <item>
      <title>Guardian Takes V-Chip Patent Suits To Fed Circ.</title>
      <link>http://www.law360.com/articles/124916</link>
      <description>Bowed but not yet broken, Guardian Media Technologies Ltd. has appealed a pair of noninfringement rulings that put leading television and DVD manufacturers &#8212; including Sony Electronics Inc., Panasonic Corp. and Toshiba America Inc. &#8212; safely beyond the reach of Guardian&#8217;s widely asserted patents for v-chip technology.</description>
      <guid>http://www.law360.com/articles/124916</guid>
    </item>
    <item>
      <title>Sony Dropped From Laptop Transmission Patent Suit</title>
      <link>http://www.law360.com/articles/125001</link>
      <description>A federal judge has dismissed Sony Electronics Inc. from an inventor's suit accusing a host of computer manufacturers of infringing a patent related to voice and data transmission signals through laptop computers. </description>
      <guid>http://www.law360.com/articles/125001</guid>
    </item>
    <item>
      <title>Section 337 Not Just For Patent Cases: Experts</title>
      <link>http://www.law360.com/articles/117730</link>
      <description>Section 337 filings at the U.S. International Trade Commission overwhelmingly involve patent infringement, but the ITC can also provide an effective forum for other types of intellectual property cases, particularly those involving gray market goods, according to experts.</description>
      <guid>http://www.law360.com/articles/117730</guid>
    </item>
    <item>
      <title>Pig Vaccine Patent Suit Against Schering Still In Play</title>
      <link>http://www.law360.com/articles/122399</link>
      <description>A federal judge on Tuesday dismissed a bid from Schering-Plough Corp. unit Intervet Inc. seeking declaratory judgment that it did not infringe a pig vaccine patent held by competitor Merial Ltd, which earlier lodged an infringement suit against Schering.</description>
      <guid>http://www.law360.com/articles/122399</guid>
    </item>
    <item>
      <title>ICS, Sony Settle Volume Control Patent Suit</title>
      <link>http://www.law360.com/articles/121984</link>
      <description>Sony Electronics Inc. has exited a suit over a patent for a volume control mechanism for televisions that International Control Systems LLC brought against the electronics maker.</description>
      <guid>http://www.law360.com/articles/121984</guid>
    </item>
    <item>
      <title>Sony, Others Score Win In DVD V-Chip Patent Feud</title>
      <link>http://www.law360.com/articles/120324</link>
      <description>A federal judge has ruled that Sony Electronics Inc., Panasonic Corp. and other manufacturers&#8217; DVD players do not infringe a widely asserted patent for v-chip censorship technology, finding that the accused devices' parental control systems are not covered by the patent.</description>
      <guid>http://www.law360.com/articles/120324</guid>
    </item>
    <item>
      <title>Wyeth Loses Bid To Oust Howrey From Stent Suit</title>
      <link>http://www.law360.com/articles/118613</link>
      <description>Howrey LLP can represent Boston Scientific Corp. in several stent patent lawsuits against Wyeth and Johnson &amp; Johnson Inc., a federal judge has said, rejecting Wyeth's complaints of conflict of interest.</description>
      <guid>http://www.law360.com/articles/118613</guid>
    </item>
    <item>
      <title>Schering Prevails In Patent Suit Over Pig Vaccine</title>
      <link>http://www.law360.com/articles/116528</link>
      <description>A federal judge has granted a summary judgment of noninfringement to Schering-Plough Corp. unit Intervet Inc. in its declaratory judgment case against rival Merial Ltd. over a patent covering a pig vaccine.</description>
      <guid>http://www.law360.com/articles/116528</guid>
    </item>
    <item>
      <title>ICR Closes Book On Patent Spat Against Sony</title>
      <link>http://www.law360.com/articles/113214</link>
      <description>Illinois Computer Research LLC has dropped its intellectual property suit against Sony Electronics Inc. over an electronic book patent ICR bought from a former Fish &amp; Richardson PC partner at the center of a legal firestorm over his intellectual property portfolio.
</description>
      <guid>http://www.law360.com/articles/113214</guid>
    </item>
    <item>
      <title>Paice Trims Hybrid Patent Suit Against Toyota</title>
      <link>http://www.law360.com/articles/112738</link>
      <description>Paice LLC has dropped certain patent infringement claims against Toyota Motor Corp. related to two Lexus models in ongoing litigation over the rights to three patents covering hybrid vehicle technology.</description>
      <guid>http://www.law360.com/articles/112738</guid>
    </item>
    <item>
      <title>Forest, Lundbeck Lose Bid To Limit Lexapro Claims</title>
      <link>http://www.law360.com/articles/109269</link>
      <description>A federal judge has rejected the latest bid from H. Lundbeck A/S and its partner Forest Laboratories Inc. to pare down a patent dispute related to the antidepressant citalopram, ruling that a lone letter from one of the companies' suppliers did not yield enough evidence to drop part of Infosint SA's infringement claims.</description>
      <guid>http://www.law360.com/articles/109269</guid>
    </item>
  </channel>
</rss>
